Lin et al. had identified casticin inhibition of PCa cell migration and invasion and downregulation of the expression of SOS1, and the findings may represent a promising therapeutic agent for metastatic PCa about SOS1 [27]. The gene discussed is SOS1; the disease is posterior cortical atrophy.